In this randomized, double-blind, parallel group, placebo-controlled, dose-ranging study, we have compared three doses (0.1 mg, 1.0 mg and 3.0 mg) of the 5-HT3 receptor antagonist, granisetron (Kytril), as prophylactic therapy for the prevention of postoperative nausea and vomiting. The aims were to determine the optimal dose of granisetron and to evaluate its safety profile. We studied 527 adu…
In this randomized, double blind, parallel group, placebo-controlled, dose-ranging study, we have compared three doses (0.1mg, 1.0 mg and 3.0mg) of the 5-HT3 receptor antagonist, granisetron (Kytril) as prophylactic therapy for the prevention of postoperative nausea and vomiting